A new take on lab testing and a pipeline of drugs have helped Opko Health rally over the past 5 years, but lately the stock has been flat. Jim Cramer speaks with …
source CNBC
Opko Health CEO Dr. Phil Frost | Mad Money | CNBC
A new take on lab testing and a pipeline of drugs have helped Opko Health rally over the past 5 years, but lately the stock has been flat. Jim Cramer speaks with …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More